Fenwal Inc. Company Profile

News Articles [ 29 Associated News Articles listed on BioPortfolio]

TEXT-S&P: Fenwal rating unchanged pending acquisition

July 23 - Standard & Poor's Ratings Services said today that its rating on Fenwal Inc. (B+/Stable/--) is unchanged by the announcement that it will be acquired by Fresenius Kabi, a wholly owned subsid...

TEXT-S&P raises Fenwal corp credit rating 'B+'

-- Lake Zurich, Ill.-based Fenwal Inc.'s financial strength has exceeded our expectations, reflecting revenue growth, EBITDA margin improvement, and debt repayment.

Fresenius Buys Fenwal for $1.1 Billion

Fresenius brushed aside difficulties acquiring Rhoen-Klinikum, instead agreeing on Friday to buy blood collection equipment specialist Fenwal Holdings in a deal sources valued at $1.1 billion. The dea...

Fresenius Kabi to Acquire Fenwal Holdings

Fresenius Kabi will acquire Fenwal Holdings, a US-based provider of transfusion technology products for blood collection, separation, and processing...

Fenwal Holdings and Its China JV Bought by Fresenius of Germany

Fenwal Holdings, a US company with a China JV, has been bought by fellow medical equipment maker Fresenius for $1.1 billion. The deal includes a China JV that Fenwal established last year with Golden...

Fresenius Kabi buys Fenwal in transfusion push

FRANKFURT, July 20 (Reuters) - Fresenius Se on Friday said Fresenius Kabi had signed a definitive agreement to acquire Fenwal Holdings Inc. for an undisclosed amount from TPG and Maverick Capital.

FDA clears Fenwal's new plasma products

Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for...

German antitrust body clears Fenwal takeover by Fresenius

DUESSELDORF, Germany, Dec 12 (Reuters) - Germany's antitrust watchdog said on Wednesday it approved the takeover of blood collection equipment specialist Fenwal Holdings by Fresenius SE .

Drugs and Medications [0 Results]

None

PubMed Articles [ 3 Associated PubMed Articles listed on BioPortfolio]

A multicenter evaluation of a new therapeutic plasma exchange procedure.

BACKGROUND: The AMICUS (Fenwal, Inc.) was cleared in the United States for platelet (PLT) and plasma collection in 1996 with subsequent clearances for the collection of other blood products. Although...

Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor cell collection to increase lymphocyte yield and reduce cross-cellular contamination.

INTRODUCTION:: Autologous HPC collection focus has been CD34+ cell yield but product content of other cells is important for patient survival, complications, and resource utilization. METHODS:: Prospe...

Storing apheresis platelets without agitation with simulated shipping conditions during two separate periods: immediately after collection and subsequently between Day 2 and Day 3.

BACKGROUND: Apheresis platelet (PLT) units are not routinely agitated during transit. Our study compared the in vitro properties of apheresis PLT units that were stored with continuous agitation (CA)...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

Fenwal Inc.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its r...

Fenwal, Inc.

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood...